Searched for
LUPIN PHARMA SEZ
Lupin gets more time from govt to complete project in Indore SEZThe company is setting up its pharma unit in Indore SEZ to manufacture pharmaceutical formulations metered dose inhalers and dry powder inh...- Lupin seeks more time from commerce ministry to complete Indore SEZ projectCompany is setting up its pharma unit in Indore SEZ to manufacture pharmaceutical formulations - metered dose inhalers and dry powder inhal...
- Share market update: Nifty Pharma index flat; Aurobindo Pharma slips 3%The Nifty Pharma index was trading 0.12 per cent down at 8894.10 around 10:29 am.
- Market Now: Sun Pharma, Aurobindo Pharma keep Nifty Pharma index upThe Nifty Pharma index was trading 0.37 per cent up at 8,876 around 01:15 pm (IST).
- Market Now: Nifty Pharma index down; Cipla, Cadila among top dragsThe Nifty Pharma index was trading 0.28 per cent down at 9,017 around 02:15 pm (IST).
- Top gainers and losers of Monday's sessionBoth the key indices, Nifty50 and Sensex, hit fresh record highs of 10,631 and 34,386, respectively, on Monday.
- Market Now: Pharma stocks in pain; Sun Pharma, Cipla decline up to 1%The Nifty Pharma index was trading 0.12 per cent down at 9,628 around 01:50 pm (IST)
- Market Now: Over 10 stocks hit fresh 52-week lowsNSE Nifty50 was trading 34 points up at 10,423, while the BSE Sensex was 105 points up at 33,707 around 11.20 am (IST).
- Most active stocks in terms of value on NSE on ThursdayThe Nifty50 index closed Thursday's session 17 points down at 10,424, while the BSE Sensex settled 27 points down at 33,573.
- Market Now: Pharma stocks fall; Cadila, Divi's Lab only gainersAmong the 51 stocks in Nifty index, 33 were trading in green, while 18 were in red.
- Sensex hits 31,000, these 35 stocks hit fresh 52-week highMarket sentiment was looking bullish on completion of the third year of Modi government.
- Infosys, Axis Bank, ITC most active stocks in terms of valueBoth NSE and BSE were trading in green in afternoon's session on Thursday.
- Market now: Lupin, HDFC, Infosys most active stocks in terms of valueThe NSE Nifty was trading 55.25 points up at 9415.80 today.
- Sharekhan’s top four investment picks in pharma spaceMost pharma companies for the quarter ended March 2013 reported strong numbers, mainly led by a strong performance in the US and emerging m...
- Pharma sector to see healthy growth, but not for all companiesThe pharma sector is likely to maintain a healthy revenue growth rate of 20-25% for the quarter ended December 2011.
- Competition to hit pharma cos like Cadila Healthcare, Divi's Labs, Lupin, Pfizer, Sun Pharma marginsPharma companies are expected to log a modest performance in the September quarter of this fiscal. Most companies are expected to post doub...
- Most pharma companies likely to see a mixed show in September quarterDr Reddy's and Cipla, the next two leading players, logged a performance similar to the one in the preceding March quarter.
- Union Budget 2011: Increased excise duty, MAT on SEZs to hurt pharma industry'There is as expected nothing for the pharma industry, expect an increase in excise duty from 4 per cent to 5 per cent.'
- Reliance Power to replace Dr Reddy's in Nifty from Sept 10Anil Ambani group-firm Reliance Power will be included in the National Stock Exchange's 50- share benchmark index Nifty with effect from Se...
- Lupin proposes to set up a SEZ in MaharashtraPharma major Lupin proposes to set up a sector-specific Special Economic Zone (SEZ) in Maharashtra to produce API and formulations with an ...
Load More
